24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Basic InformationLookupsLatest News
Long-Haul COVID in Kids Typically Ends Within 3 Months: StudyPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotCommon Eye Conditions Tied to Higher Risk for DementiaDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: StudyWHO Says Africa Will Get 30% of COVID Vaccines It Needs by FebruaryCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciEbola Vaccine Effective in African Clinical TrialBritain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid LockdownsIsraeli Data on COVID Boosters to Be Published This Week in Major JournalData Doesn't Support Need for COVID-19 Vaccine Boosters: ExpertsCOVAX Cuts Global COVID Vaccine Supply Estimates By a QuarterMonth-Long Recovery From Concussion Is Normal: StudyDeath From COVID 11 Times More Likely If You're Unvaccinated: StudyL.A. Is First Major School District to Mandate Vaccines for Students 12 and UpNew Tally Adds Extra 16,000 U.S. Nursing Home Residents Lost to COVIDBlack Americans, Mexican Americans Develop Diabetes Earlier in LifeAverage COVID Hospitalization Is 150 Times More Expensive Than VaccinationGetting Your First COVID Shot Can Boost Mental Health: StudyVaccinated Have 1 in 13,000 Chance of Breakthrough Case Needing HospitalizationBiden Issues Tough New Vaccine Mandates Affecting Millions of U.S. WorkersTime Is Brain: Mobile Stroke Units Reduce Disability, Study FindsWildfires Cause More Than 33,000 Deaths Globally Each YearIs Your Workplace an Asthma Trigger?Biden to Strengthen Push for Vaccine Mandates in New COVID PlanAHA News: How a Simple Tape Measure May Help Predict Diabetes in Black AdultsEczema Can Take Toll on Child's Mental HealthNo Lasting Damage to Lungs After COVID in Young Patients: StudyAdults With Autism, Mental Illness May Be at Higher Risk for Severe COVIDIn Cancer Patients, COVID Vaccine Immunity at 6 Months Is Similar to General PopulationNew Insights Into Why Asthma Worsens at NightHere's How COVID-19 Can Affect Your MouthPet Dogs Can Alert Owners to Epileptic SeizuresU.S. COVID-19 Cases Now Top 40 MillionWhy Aren't COVID Vaccines Getting to People Globally?
Questions and AnswersLinks
Related Topics


Major Study Finds No Serious Health Issues From Pfizer, Moderna Vaccines

HealthDay News
by Steven Reinberg
Updated: Sep 3rd 2021

new article illustration

FRIDAY, Sept. 3, 2021 (HealthDay News) -- An ongoing study of more than 6 million Americans found no serious side effects linked to mRNA COVID-19 vaccines.

"These results from our safety surveillance are reassuring," said Dr. Nicola Klein, director of the Kaiser Permanente Vaccine Study Center in Oakland, Calif. She spoke in a Kaiser Permanente news release.

Klein is also a leader of Vaccine Safety Datalink (VSD), which studies patient records for 12 million Americans. The project is supported by the U.S. Centers for Disease Control and Prevention.

The Journal of the American Medical Association published Datalink's first comprehensive findings on Sept. 2.

The study found no serious health effects that could be tied to the Pfizer-BioNTech or Moderna COVID-29 vaccines. Monitoring will continue for two years.

The findings span mid-December 2020 through June 26, 2021. Researchers compared specific side effects in the first three weeks after mRNA shots with those three to six weeks later. In all, 6.2 million people were studied after the first dose and 5.7 million after the second dose.

The researchers looked for 23 potential health problems that have followed other vaccinations or had been reported by patients.

These included neurological disorders such as encephalitis and myelitis, seizures and Guillain-Barré syndrome, as well as cardiovascular problems such as acute heart attack, stroke and pulmonary embolism. Others examined included Bell's palsy, appendicitis, anaphylaxis and multisystem inflammatory syndrome.

None rose to a level that was statistically significant after mRNA COVID shots, the analysis found.

Researchers highlighted their findings about cases of confirmed myocarditis and pericarditis among young people, which has become an outcome of concern. Myocarditis is an inflammation of the heart, and pericarditis is inflammation of the sac surrounding it.

The study found 34 such cases in patients between 12 and 39 years of age -- 85% were male and 82% were hospitalized for a median time of one day, meaning half were hospitalized longer, half for a shorter time. Nearly all recovered by the time the review took place, the researchers said.

They calculated that in the 12- to 39-year-old age group, there is a risk of 6.3 additional cases of myocarditis per million in the week after vaccination. That's significantly less than the risk linked to COVID-19 itself, the study authors noted.

"The results of this study are a great example of how seriously CDC takes vaccine safety, and how thorough and transparent we are in our safety monitoring efforts," said Dr. Tom Shimabukuro, deputy director of CDC's Immunization Safety Office.

"It is our top priority to do the science and communicate quickly and clearly with health care providers and the public, as COVID-19 vaccines continue to undergo the most intensive safety monitoring in U.S. history," he added. "Getting vaccinated remains the best way to protect yourself and your loved ones against a virus that has taken millions of lives."

Some early findings had been summarized and reported at public meetings of the CDC's Advisory Committee on Immunization Practices, though the JAMA article is the VSD's first major report of its safety surveillance of the Pfizer and Moderna vaccines.

More information

To learn more about COVID-19 vaccines, visit the U.S. Centers for Disease Control and Prevention.

SOURCE: Kaiser Permanente, news release, Sept. 3, 2021